Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.
2.

Vascular chymase: pathophysiological role and therapeutic potential of inhibition.

Doggrell SA, Wanstall JC.

Cardiovasc Res. 2004 Mar 1;61(4):653-62. Review.

3.

Chymase: its pathophysiological roles and inhibitors.

Fukami H, Okunishi H, Miyazaki M.

Curr Pharm Des. 1998 Dec;4(6):439-53. Review.

PMID:
10197055
4.
5.

Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models.

Miyazaki M, Takai S, Jin D, Muramatsu M.

Pharmacol Ther. 2006 Dec;112(3):668-76. Review.

PMID:
16837049
6.

Tissue angiotensin II generating system by angiotensin-converting enzyme and chymase.

Miyazaki M, Takai S.

J Pharmacol Sci. 2006;100(5):391-7. Review.

7.

Local angiotensin II-generating system in vascular tissues: the roles of chymase.

Miyazaki M, Takai S.

Hypertens Res. 2001 May;24(3):189-93. Review.

8.

[Angiotensin II formation by chymase in the cardiovascular tissue].

Okunishi H.

Nihon Yakurigaku Zasshi. 1998 Sep;112(3):203-12. Review. Japanese.

PMID:
9793075
9.

[Pathophysiological roles of chymase and effects of chymase inhibitor].

Takai S, Jin D, Miyazaki M.

Nihon Yakurigaku Zasshi. 1999 Oct;114 Suppl 1:41P-47P. Review. Japanese.

PMID:
10629853
10.

A new myocardial conversion of angiotensin I.

Ferrario CM, Chappell MC.

Curr Opin Cardiol. 1994 Sep;9(5):520-6. Review.

PMID:
7987030
11.

Chymase-dependent angiotensin II forming systems in humans.

Urata H, Nishimura H, Ganten D.

Am J Hypertens. 1996 Mar;9(3):277-84. Review.

PMID:
8695029
12.

Angiotensin I converting enzyme and chymase in cardiovascular tissues.

Nishimura H, Hoffmann S, Baltatu O, Sugimura K, Ganten D, Urata H.

Kidney Int Suppl. 1996 Jun;55:S18-23. Review.

PMID:
8743505
13.

Effect of chymase inhibitor on vascular proliferation.

Takai S, Miyazaki M.

Jpn J Pharmacol. 2002 Nov;90(3):223-7. Review.

14.

Angiotensin II formation in the human heart: an ACE or non-ACE-mediated pathway?

Kokkonen JO, Saarinen J, Kovanen PT.

Ann Med. 1998 Aug;30 Suppl 1:9-13. Review.

PMID:
9800878
15.

Novel insights into the biological function of mast cell carboxypeptidase A.

Pejler G, Knight SD, Henningsson F, Wernersson S.

Trends Immunol. 2009 Aug;30(8):401-8. doi: 10.1016/j.it.2009.04.008. Review.

PMID:
19643669
16.

Mechanisms of angiotensin II formation in humans.

Urata H, Nishimura H, Ganten D.

Eur Heart J. 1995 Dec;16 Suppl N:79-85. Review.

PMID:
8682066
17.

Angiotensin II-generating enzymes.

Belova LA.

Biochemistry (Mosc). 2000 Dec;65(12):1337-45. Review.

PMID:
11173502
18.

Chymase-derived angiotensin II and arrhythmias after myocardial infarction.

Jin D, Takai S, Okamoto Y, Muramatsu M, Miyazaki M.

Nihon Yakurigaku Zasshi. 2004 Aug;124(2):77-82. Review.

PMID:
15277725
19.

Endothelin-1 (1-31): from chymase-dependent synthesis to cardiovascular pathologies.

D'Orléans-Juste P, Houde M, Rae GA, Bkaily G, Carrier E, Simard E.

Vascul Pharmacol. 2008 Aug-Sep;49(2-3):51-62. doi: 10.1016/j.vph.2008.06.007. Review.

PMID:
18675382
20.

[Pathophysiological roles of human chymase].

Nakayama S, Urata H, Arakawa K.

Nihon Rinsho. 1997 Aug;55(8):1903-8. Review. Japanese.

PMID:
9284400
Items per page

Supplemental Content

Support Center